Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1Phase 3 1

Status

Terminated 1Recruiting 1Completed 1Active not recruiting 1

Sponsor Class

INDUSTRY 3OTHER 1

Study Type

Interventional 4

Sponsor

Cancer Type

Plasma cell 7Lymphoid 7Other hematologic neoplasm 5Thoracic 4Genitourinary 4Gynecologic 3Breast 3Myeloid 2Head & Neck 2Sarcoma 1Other solid neoplasm 1Other neoplasm 1Gastrointestinal 1Dermatologic 1

Conditions

Parkinson Disease 4, Autosomal Dominant Lewy Body 2Lung Neoplasms 2Carcinoma, Non-Small-Cell Lung 2Emergence Delirium 1Delirium 1

Interventions

Carboplatin 347pembrolizumab 322Pemetrexed 246Cisplatin 218Paclitaxel 147Nivolumab 138durvalumab 133osimertinib 112Docetaxel 111atezolizumab 109Specimen Handling 91Radiotherapy 87Drug Therapy 85Magnetic Resonance Spectroscopy 77Etoposide 76Radiosurgery 72Gemcitabine 71Ipilimumab 55130-nm albumin-bound paclitaxel 54Bevacizumab 52cemiplimab 47tislelizumab 44Blood Specimen Collection 40Cetuximab 35Taxes 34Platinum 33Injections 33Biopsy 33Standard of Care 31Immunoglobulin G 30

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Acetaminophen × Thoracic × 1 year × Clear all
NCT06788912 2026-06-01

MK-3475-01E

Merck Sharp & Dohme LLC

Phase 2 Recruiting
60 enrolled
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Lung Neoplasms

NCT06305754 2026-05-29

MK-2870-009

Merck Sharp & Dohme LLC

Phase 3 Active not recruiting
520 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT04165096 2026-05-13

MK-3475-01C

Merck Sharp & Dohme LLC

Phase 2 Completed
128 enrolled 14 charts
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT05834569 2025-09-05

Impact of Maxigesic on Delirium After Minimally Invasive Lung Surgery in Elderly Patients

Korea University Guro Hospital

Phase 4 Terminated
25 enrolled
Thoracic

Emergence Delirium, Delirium, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡